A randomized, controlled 24-week study of intermittent subcutaneous interleukin-2 in HIV-1 infected patients in Thailand

• Main Authors: Kiat Ruxrungtham, Surapol Suwanagool, Jorge A. Tavel, Mena Chuenyam, Eugene Kroon, Sasiwimol Ubolyam, Supranee Buranapraditkun, Wichai Techasathit, Yeuming Li, Sean Emery, Richard T. Davey, Lisa Fosdick, Chaiyos Kunanusont, H. Clifford Lane, Praphan Phanuphak
• 其他作者: Chulalongkorn University
• 格式: Article
• 出版: 2018
• 主題: Immunology and Microbiology; Medicine
• 在線閱讀: https://repository.li.mahidol.ac.th/handle/123456789/25960

Objectives: To assess the immunological and virological effects, safety profile and feasibility of subcutaneous interleukin-2 (sclL-2) therapy in an HIV-infected Thai population. Design: Seventy-two patients with baseline CD4 cell count of ≥ 350 x 106/l and no history of opportunistic infection were...